Friday, December 16, 2022 9:08:01 AM
The fact that good ol David Rectum Koos has NEVER EVER mentioned it being an issue in affecting the stock.
Why is that?
BECAUSE IT ISN'T AN ISSUE.
Don't you think that the business leader Koos, as other competent CEOs have in the past done, would have brought up this issue as affecting the pps if he thought it was happening to the level that we are being told it is?
OF course he would! But it isn't because the baseless posts about naked shorting is just they typical misinformation to try and explain away the real reason why the pps is where it is. And it's all about lack of execution, dilution, and no business prospects for REGEN. Everything Koos touches turns to crap.
Where is oncofakeapharma?
Where is that CSO?
Where is that CFO?
Where is that Lilly deal?
Where is Kesari?
Where is the reactivation of the INDs with the FDA?
Where is Hemaxellerate trials?
Where is the funding?
The naked shorting canard is misinformation and the true traders know this.
FACTS are stubborn things
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM